Primary chemotherapy for operable breast cancer: Incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conservingsurgery
R. Rouzier et al., Primary chemotherapy for operable breast cancer: Incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conservingsurgery, J CL ONCOL, 19(18), 2001, pp. 3828-3835
Purpose: To determine the incidence and the prognostic value of ipsilateral
breast tumor recurrence (IBTR) in patients treated with primary chemothera
py and breast-conserving surgery.
Patients and Method: Between January 1985 and December 1994, 257 patients w
ith invasive T1 to T3 breast carcinoma were treated with primary chemothera
py, lumpectomy, and radiation therapy. The median follow-up time was 93 mon
ths. To evaluate the role of IBTR in metastase-free survival, a Cox regress
ion multivariate analysis was performed using IBTR as a time-dependent cova
riate.
Results: The IBTR rates were 16% (+/- 2.4%) at 5 years and 21.5% (+/- 3.2%)
at 10 years. Multivariate analysis showed that the probability of local co
ntrol was decreased by the following independent factors: age less than or
equal to 40 years, excision margin less than or equal to 2 mm, S-phase frac
tion more than 4%, and clinical tumor size more than 2 cm at the time of su
rgery. In patients with excision margins of more than 2 mm, the IBTR. rates
were 12.7% at 5 years and 17% at 10 years. Nodal status, age less than or
equal to 40 years, and negative estrogen receptor status were predictors of
distant disease in the Cox multivariate model with fixed covariates. The c
ontribution of IBTR was highly significant (relative risk = 5.34) when adde
d to the model, whereas age:5 40 years was no longer significant. After IBT
R, 31.4% (+/- 7.0%) of patients developed metastases at 2 years and 59.7% (
+/- 8.1 %) at 5 years. Skin involvement, size at initial surgery, and estro
gen receptor status were predictors of metastases after IBTR.
Conclusion: IBTR is a strong predictor for distant metastases. There are im
plications for conservative surgery after downstaging of the tumor and ther
apy at the time of IBTR. J Clin Oncol 19:3828-3835. (C) 2001 by American So
ciety of Clinical Oncology.